Article
Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.
Endocrine-related cancer - 1 Dec 2008
Goodman Marc T, Lurie Galina, Thompson Pamela J, McDuffie Katharine E, Carney Michael E
Abstract excerpt
Although the role of estrogen in the etiology of ovarian cancer is uncertain, there is increasing evidence that hormone replacement therapy is a risk factor for ovarian malignancy. The production of estrogen involves the conversion of androgens via P450 aromatase, encoded by the CYP19A1 gene. Genetic variation in two CYP19A1 single-nucleotide polymorphisms (SNPs), rs749292 and rs727479, has been found to produce...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
